FERRING

REFERENCES: 1. Data on File, Ferring Pharmaceuticals, Parsippany, NJ. 2. Rolling 12-month average of IQVIA claims data based on unique patient (August 2021-August 2022). 3. Subject to change based on individual plan coverage. This site is intended for US health care professionals. EUFLEXXA® is a registered trademark of Ferring B.V. All other trademarks are property of their respective owners. ©2022 Ferring B.V. All rights reserved. US-EU-2000050 10/22... EUFLEXXA® (1% sodium hyaluronate) is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and simple analgesics (eg, acetaminophen).

Also known as: Ferring B.V